Allergan plc
(NYSE : AGN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
0.19%140.292.8%$262.11m
ZTSZoetis, Inc. Class A
1.04%99.001.9%$185.31m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
0.99%14.362.0%$163.20m
MYLMylan N.V.
0.45%26.853.2%$118.36m
TXMDTherapeuticsMD, Inc.
0.71%4.2325.3%$9.76m
TAROTaro Pharmaceutical Industries Ltd.
0.97%103.836.4%$7.53m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
1.39%40.802.0%$7.22m
ABEOAbeona Therapeutics, Inc.
-2.69%7.967.8%$3.08m
JAGXJaguar Animal Health, Inc.
-2.77%0.249.8%$3.05m
KINKindred Biosciences, Inc.
0.69%8.740.3%$1.90m
LFVNLifeVantage Corporation
0.09%11.063.3%$1.32m
PETXAratana Therapeutics, Inc.
-0.85%3.508.5%$0.89m
CPHIChina Pharma Holdings, Inc.
-1.42%0.360.1%$0.59m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.